Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-16 3:58 pm Purchase | 2021-02-16 | 13G | OneSpaWorld Holdings Limited OSW | Capital Research Global Investors | 4,896,238 7.200% | 4,896,238 (New Position) | Filing History |
| 2021-02-16 3:58 pm Sale | 2021-02-16 | 13G | Old Dominion Freight Line, Inc. ODFL | Capital Research Global Investors | 16,974,172 7.200% | -4,907,810 (-22.43%) | Filing History |
| 2021-02-16 3:58 pm Purchase | 2021-02-16 | 13G | BioMarin Pharmaceutical Inc. BMRN | Capital Research Global Investors | 22,193,527 12.200% | 189,462 (+0.86%) | Filing History |
| 2021-02-16 3:58 pm Purchase | 2021-02-16 | 13G | Granite Construction Incorporated GVA | Capital Research Global Investors | 3,365,500 7.200% | 3,365,500 (New Position) | Filing History |
| 2021-02-16 3:58 pm Purchase | 2021-02-16 | 13G | New Frontier Health Corporation NFH | Capital Research Global Investors | 12,173,386 9.300% | 12,173,386 (New Position) | Filing History |
| 2021-02-16 3:58 pm Purchase | 2021-02-16 | 13G | GW PHARMACEUTICALS PLC GWPH | Capital Research Global Investors | 44,834,512 12.000% | 44,834,512 (New Position) | Filing History |
| 2021-02-16 3:53 pm Purchase | 2021-02-16 | 13G | Cenovus Energy Inc. CVE | Capital Research Global Investors | 145,740,343 11.900% | 2,375,452 (+1.66%) | Filing History |
| 2021-02-16 3:52 pm Purchase | 2021-02-16 | 13G | Kronos Bio, Inc. KRON | Capital Research Global Investors | 3,541,573 6.300% | 3,541,573 (New Position) | Filing History |
| 2021-02-16 3:46 pm Sale | 2021-02-16 | 13G | MercadoLibre, Inc. MELI | Capital Research Global Investors | 2,885,754 5.800% | -737,584 (-20.36%) | Filing History |
| 2021-02-16 3:46 pm Unchanged | 2021-02-16 | 13G | Gilead Sciences, Inc. GILD | Capital Research Global Investors | 121,672,399 9.700% | 0 (Unchanged) | Filing History |
| 2021-02-16 3:46 pm Purchase | 2021-02-16 | 13G | Cannae Holdings, Inc. CNNE | Capital Research Global Investors | 7,467,877 8.100% | 809,118 (+12.15%) | Filing History |
| 2021-02-16 3:46 pm Sale | 2021-02-16 | 13G | Abbott Laboratories ABT | Capital Research Global Investors | 86,394,199 4.900% | -27,295,094 (-24.01%) | Filing History |
| 2021-02-16 3:46 pm Sale | 2021-02-16 | 13G | AbbVie Inc. ABBV | Capital Research Global Investors | 37,921,062 2.100% | -48,681,631 (-56.21%) | Filing History |
| 2021-02-16 3:46 pm Sale | 2021-02-16 | 13G | CONCHO RESOURCES, INC CXO | Capital Research Global Investors | 9,112,695 4.600% | -3,333,002 (-26.78%) | Filing History |
| 2021-02-16 3:46 pm Purchase | 2021-02-16 | 13G | Alcon Inc. ALC | Capital Research Global Investors | 6,812,420 1.400% | 6,812,420 (New Position) | Filing History |
| 2021-02-16 3:46 pm Purchase | 2021-02-16 | 13G | Allakos Inc. ALLK | Capital Research Global Investors | 6,338,967 12.100% | 952,122 (+17.67%) | Filing History |
| 2021-02-16 3:46 pm Sale | 2021-02-16 | 13G | ATI Inc. ATI | Capital Research Global Investors | 0 0.000% | -6,646,030 (Position Closed) | Filing History |
| 2021-02-16 3:46 pm Purchase | 2021-02-16 | 13G | Allogene Therapeutics, Inc. ALLO | Capital Research Global Investors | 12,640,338 9.000% | 6,097,660 (+93.20%) | Filing History |
| 2021-02-16 3:46 pm Purchase | 2021-02-16 | 13G | Alteryx, Inc. AYX | Capital Research Global Investors | 3,630,811 6.700% | 3,630,811 (New Position) | Filing History |
| 2021-02-16 3:46 pm Unchanged | 2021-02-16 | 13G | ALUMINUM CORPORATION OF CHINA LIMITED | Capital Research Global Investors | 0 0.000% | 0 (Unchanged) | Filing History |